Literature DB >> 18682342

Intent to receive an HPV vaccine among university men and women and implications for vaccine administration.

Melissa Jones1, Robert Cook.   

Abstract

OBJECTIVE AND PARTICIPANTS: In 2006, the authors examined intention to receive an HPV vaccine among 340 college students.
METHODS: A total of 138 men and 202 women completed questionnaires. The authors measured intention by asking participants how likely they would be to accept an HPV vaccine that prevented against (1) all HPV, (2) cervical cancer but not genital warts, (3) genital warts but not cervical cancer, and (4) both genital warts and cervical cancer.
RESULTS: Men and women reported high intent to receive an HPV vaccine, although women did so at a significantly higher rate (77.5% vs 88.6%, respectively; p < .01). Men were less willing to receive a vaccine that prevents cervical cancer alone than they were to receive one that prevents cervical cancer and genital warts (34.1% vs 77.5%, p < .001). Intent to receive the vaccine was significantly greater among participants who reported more than 5 sex partners and correctly answered 2 or 3 HPV knowledge questions.
CONCLUSIONS: Interest varied according to sexual history, according to knowledge about HPV, and (in men) according to vaccine target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682342     DOI: 10.3200/JACH.57.1.23-32

Source DB:  PubMed          Journal:  J Am Coll Health        ISSN: 0744-8481


  40 in total

1.  Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability?

Authors:  Annie-Laurie McRee; Paul L Reiter; Kim Chantala; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Human papillomavirus vaccine intent and uptake among female college students.

Authors:  Divya A Patel; Melissa Zochowski; Stephanie Peterman; Amanda F Dempsey; Susan Ernst; Vanessa K Dalton
Journal:  J Am Coll Health       Date:  2012

3.  Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample.

Authors:  Ellen M Daley; Stephanie L Marhefka; Eric R Buhi; Cheryl A Vamos; Natalie D Hernandez; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

4.  Sexual health behaviors in a random sample of students at a Mid-Atlantic university: 2010-2011.

Authors:  Emily L McCave; Ilana R Azulay Chertok; Virginia Ramseyer Winter; Zelalem T Haile
Journal:  J Community Health       Date:  2013-04

5.  The Male Factor: Human Papillomavirus (HPV) and HPV4 Vaccine Acceptance Among African American Young Men.

Authors:  Jennifer A Sledge
Journal:  J Community Health       Date:  2015-08

6.  Acceptability of HPV vaccine among a national sample of gay and bisexual men.

Authors:  Paul L Reiter; Noel T Brewer; Annie-Laurie McRee; Paul Gilbert; Jennifer S Smith
Journal:  Sex Transm Dis       Date:  2010-03       Impact factor: 2.830

7.  Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men.

Authors:  Paul L Reiter; Noel T Brewer; Jennifer S Smith
Journal:  Sex Transm Infect       Date:  2009-11-30       Impact factor: 3.519

8.  Do correlates of HPV vaccine initiation differ between adolescent boys and girls?

Authors:  Melissa B Gilkey; Jennifer L Moss; Annie-Laurie McRee; Noel T Brewer
Journal:  Vaccine       Date:  2012-07-27       Impact factor: 3.641

9.  Drivers and barriers to acceptance of human-papillomavirus vaccination among young women: a qualitative and quantitative study.

Authors:  Gitte Lee Mortensen
Journal:  BMC Public Health       Date:  2010-02-14       Impact factor: 3.295

10.  HPV knowledge and vaccine acceptability among Hispanic fathers.

Authors:  Julie Kornfeld; Margaret M Byrne; Robin Vanderpool; Sarah Shin; Erin Kobetz
Journal:  J Prim Prev       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.